Results of an early access treatment protocol of daratumumab in United States patients with relapsed or refractory multiple myeloma

Cancer, EarlyView.

Source: Cancer - November 5, 2018 Category: Cancer & Oncology Authors: Ajai Chari, Sagar Lonial, Tomer M. Mark, Amrita Y. Krishnan, Keith E. Stockerl ‐Goldstein, Saad Z. Usmani, Anil Londhe, Delores Etheredge, Sarah Fleming, Baolian Liu, Jon Ukropec, Thomas S. Lin, Sundar Jagannath, Ajay K. Nooka Source Type: research